These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16006765)

  • 1. Treatment of cryptosporidiosis in immunocompromised hosts.
    Zardi EM; Picardi A; Afeltra A
    Chemotherapy; 2005 Jul; 51(4):193-6. PubMed ID: 16006765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus infection and cryptosporidiosis: protective immune responses.
    Flanigan TP
    Am J Trop Med Hyg; 1994; 50(5 Suppl):29-35. PubMed ID: 8203720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intestinal cryptosporidiosis in HIV infected children].
    Barboni G; Candi M; Inés Villacé M; Leonardelli A; Balbaryski J; Gaddi E
    Medicina (B Aires); 2008; 68(3):213-8. PubMed ID: 18689152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.
    Hommer V; Eichholz J; Petry F
    J Antimicrob Chemother; 2003 Sep; 52(3):359-64. PubMed ID: 12888587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host immune response to Cryptosporidium parvum infection.
    Petry F; Jakobi V; Tessema TS
    Exp Parasitol; 2010 Nov; 126(3):304-9. PubMed ID: 20685209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary cryptosporidiosis in an AIDS patient: successful treatment with paromomycin plus azithromycin.
    Palmieri F; Cicalini S; Froio N; Rizzi EB; Goletti D; Festa A; Macrí G; Petrosillo N
    Int J STD AIDS; 2005 Jul; 16(7):515-7. PubMed ID: 16004637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cryptosporidium infection in patients with major histocompatibility complex class II deficiency syndrome in Tunisia: description of five cases].
    Ben Abda I; Essid R; Mellouli F; Aoun K; Bejaoui M; Bouratbine A
    Arch Pediatr; 2011 Sep; 18(9):939-44. PubMed ID: 21816586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular targets for detection and immunotherapy in Cryptosporidium parvum.
    Boulter-Bitzer JI; Lee H; Trevors JT
    Biotechnol Adv; 2007; 25(1):13-44. PubMed ID: 17055210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indinavir reduces Cryptosporidium parvum infection in both in vitro and in vivo models.
    Mele R; Gomez Morales MA; Tosini F; Pozio E
    Int J Parasitol; 2003 Jul; 33(7):757-64. PubMed ID: 12814654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapeutic approaches to cryptosporidiosis in immunocompromised patients.
    Hoepelman AI
    J Antimicrob Chemother; 1996 May; 37(5):871-80. PubMed ID: 8737137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P receptor antagonism for treatment of cryptosporidiosis in immunosuppressed mice.
    Robinson P; Martin P; Garza A; D'Souza M; Mastrangelo MA; Tweardy D
    J Parasitol; 2008 Oct; 94(5):1150-4. PubMed ID: 18576802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health sequelae of human cryptosporidiosis in immunocompetent patients.
    Hunter PR; Hughes S; Woodhouse S; Raj N; Syed Q; Chalmers RM; Verlander NQ; Goodacre J
    Clin Infect Dis; 2004 Aug; 39(4):504-10. PubMed ID: 15356813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptosporidiosis: host immune responses and the prospects for effective immunotherapies.
    McDonald V
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1077-86. PubMed ID: 22029525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group.
    Hewitt RG; Yiannoutsos CT; Higgs ES; Carey JT; Geiseler PJ; Soave R; Rosenberg R; Vazquez GJ; Wheat LJ; Fass RJ; Antoninievic Z; Walawander AL; Flanigan TP; Bender JF
    Clin Infect Dis; 2000 Oct; 31(4):1084-92. PubMed ID: 11049793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptosporidium parvum-associated sclerosing cholangitis in a liver transplant patient.
    Denkinger CM; Harigopal P; Ruiz P; Dowdy LM
    Transpl Infect Dis; 2008 Apr; 10(2):133-6. PubMed ID: 17605744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on: effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.
    Dugue GA
    J Antimicrob Chemother; 2004 Feb; 53(2):403; author reply 403. PubMed ID: 14729752
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of HIV-protease inhibitors on opportunistic parasites.
    Pozio E; Morales MA
    Trends Parasitol; 2005 Feb; 21(2):58-63. PubMed ID: 15664527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cryptosporidiosis: do we know what we think we know?
    Cabada MM; White AC
    Curr Opin Infect Dis; 2010 Oct; 23(5):494-9. PubMed ID: 20689422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.